DNAPrint Genomics (DNAG) Stock Price, News & Analysis

Company Overview

DNAPrint Genomics (OTCMKTS:DNAG) is a molecular diagnostics company specializing in direct-to-consumer and clinical genetic testing services. The company’s core offerings include ancestry determination tests that estimate an individual’s ethnic origins and geographic lineage by analyzing autosomal DNA markers. In addition, DNAPrint Genomics has developed nutrigenomic and pharmacogenomic panels designed to provide insights into how genetic variations may influence dietary responses and drug metabolism.

Through its online platform and partnerships with healthcare practitioners, DNAPrint Genomics delivers customized reports that integrate genetic profiles with ancestral and wellness information. The company’s products are marketed under branded services that guide users in interpreting their genetic data and making informed lifestyle or medical decisions. DNAPrint Genomics has also collaborated with research institutions to expand its test catalog and validate new genetic markers for population studies.

Founded in the early 2000s and headquartered in Gainesville, Florida, DNAPrint Genomics has pursued a strategy of global distribution, with service availability in North America, Europe and select Asian markets. While detailed leadership information is limited, the company’s management team has historically included professionals with backgrounds in molecular biology, bioinformatics and consumer health. DNAPrint Genomics continues to position itself in the personalized medicine space by leveraging advances in genomic technology and data analytics.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 90 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DNAG Stock Analysis - Frequently Asked Questions

How do I buy shares of DNAPrint Genomics?

Shares of DNAG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of DNAPrint Genomics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DNAPrint Genomics investors own include Editas Medicine (EDIT), Pacira BioSciences (PCRX), BioStem Technologies (BSEM), Berkshire Hathaway (BRK.B), Bristol Myers Squibb (BMY), Bitwise Crypto Industry Innovators ETF (BITQ) and Black Diamond Therapeutics (BDTX).

Company Calendar

• Today: 10/24/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:DNAG
• CIK: N/A
• Web: www.dnaprint.com
• Phone: (941) 366-3400
• Fax: 941-952-9770
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -0.49